Abstract Changes in the cholinergic, serotonergic, noradrenergic, dopaminergic, GABAergic
and somatostatinergic neurons were investigated to determine their roles in Alzheimer's …

Cholinergic markers, neuropeptides, and amines and their metabolites were sampled from
identical specimens across 10 neocortical regions in a large sample of Alzheimer's disease …

Multiple neurotransmitter systems are affected in senile dementia of the Alzheimer's type
(SDAT). Among them, acetylcholine has been most studied. It is now well accepted that the …

Involvement of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's
disease/senile dementia of Alzheimer type (AD/SDAT) was studied in 20 histologically …

Autopsy studies indicating that cholinergic neurons are selectively lost in patients with
Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) suggest that …

In Alzheimer disease (AD), dysfunction in several neuronal systems is associated with
alterations in neurotransmitter receptors. Although receptors are important components of …

To investigate changes in the somatostatinergic neurons of patients with Alzheimer's
disease (AD), we determined the somatostatin-like immunoreactivity (SLI) in post-mortem …

Publisher Summary This chapter describes the cholinergic system in Alzheimer disease
(AD). Choline acetyltransferase (ChAT), the synthetic enzyme for acetylcholine (ACh), is …

Markers of serotonin synapses in entire temporal lobe and frontal and temporal neocortex
were examined for changes in Alzheimer's disease by use of both neurosurgical and …

The relationships between neurofibrillary tangles (NFT), senile plaques (SP), and the deficits
in somatostatin (SRIH) and choline acetyltransferase (ChAT) levels were determined in …